Inhibiting the NLRP3 Inflammasome With McC950 Promotes Non-Phlogistic Clearance of Amyloid-Β and Cognitive Function in APP/PS1 Mice

Brain, Behavior, and Immunity - United States
doi 10.1016/j.bbi.2016.12.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction: Neuroprotective Effects of Bajijiasu Against Cognitive Impairment Induced by Amyloid-Β in APP/PS1 Mice

Oncotarget
Oncology
2018English

Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal Β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice

Frontiers in Immunology
AllergyImmunology
2019English

LCAT Deficiency Does Not Impair Amyloid Metabolism in APP/PS1 Mice

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2014English

Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia

Frontiers in Oncology
Cancer ResearchOncology
2018English

Comment on “Deficient NLRP3 and AIM2 Inflammasome Function in Autoimmune NZB Mice”

Journal of Immunology
AllergyImmunology
2015English

Cognitive Impairment in Humanized APP×PS1 Mice Is Linked to Aβ1–42 and NOX Activation

Neurobiology of Disease
Neurology
2011English

Exercise-Induced Cognitive Improvement Is Associated With Sodium Channel-Mediated Excitability in APP/PS1 Mice

Neural Plasticity
Neurology
2020English

Selective Loss of Noradrenaline Exacerbates Early Cognitive Dysfunction and Synaptic Deficits in APP/PS1 Mice

Biological Psychiatry
Biological Psychiatry
2013English

ApoA-I Deficiency Increases Cortical Amyloid Deposition, Cerebral Amyloid Angiopathy, Cortical and Hippocampal Astrogliosis, and Amyloid-Associated Astrocyte Reactivity in APP/PS1 Mice

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy